| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $627.4M | +11.9% |
| Cost of Revenue | $141.3M | +12.1% |
| Gross Profit | $486.1M | +11.9% |
| R&D Expense | $139.0M | +3.4% |
| SG&A Expense | $136.6M | +1.0% |
| Operating Income | -$69.1M | +40.0% |
| Interest Expense | $3.8M | +4.4% |
| Pre-tax Income | -$64.8M | +39.9% |
| Income Tax | $3.7M | +62.2% |
| Net Income | -$68.5M | +37.8% |
| EPS (Basic) | -$0.53 | +39.8% |
| EPS (Diluted) | -$0.53 | +39.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $224.7M | -7.8% |
| Accounts Receivable | $138.8M | +28.2% |
| Current Assets | $424.7M | +5.5% |
| Total Assets | $1.58B | -0.6% |
| Current Liabilities | $421.4M | -0.2% |
| Total Liabilities | $864.2M | -0.9% |
| Stockholders' Equity | $716.0M | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $31.2M | -13.3% |
| Capital Expenditures | $9.0M | +207.1% |
| Investing Cash Flow | -$11.8M | +47.5% |
| Financing Cash Flow | -$41.6M | -881.9% |
| Free Cash Flow | $22.2M | -32.8% |